Prolactin and the prolactin receptor: new targets of an old hormone

References

• Ben-Jonathan N, Mershon JL, Allen DL, Steinmetz RW. Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr Rev 1996;17:639–69.
   Google Scholar
• Freeman ME, Kanyicska B, Lerant A, Nagy G. Prolactin: structure, function, and regulation of secretion. Physiol Rev 2000;80:1523–631.
   PubMed Web of Science ®Google Scholar
• Berwaer M, Monget P, Peers B, Mathy-Hartert M, Bellefroid E, Davis JR, et al. Multihormonal regulation of the human prolactin gene expression from 5000 bp of its upstream sequence. Mol Cell Endocrinol 1991;80: 53–64.
   Google Scholar
• Berwaer M, Martial JA, Davis JR. Characterization of an up-stream promoter directing extrapituitary expression of the human prolactin gene. Mol Endocrinol 1994;8:635–42.
   Google Scholar
• Sinha YN. Structural variants of prolactin: occurrence and physiological significance. Endocr Rev 1995;16:354–69.
   PubMed Web of Science ®Google Scholar
• Emanuele NV, Jurgens JK, Halloran MM, Tentler JJ, Lawrence AM, Kelley MR. The rat prolactin gene is expressed in brain tissue: detection of normal and alternatively spliced prolactin messenger RNA. Mol Endocrinol 1992;6:35–42.
   PubMedGoogle Scholar
• Sinha YN, Ott K, Vanderlaan WP. Detection of multiple PRL- and GH-like proteins in human pituitary by Western blot analysis. Am J Med Sci 1987;294:15–25.
   Google Scholar
• Sinha YN, Jacobsen BP. Structural and immunologic evi-dence for a small molecular weight 21K variant of prolactin. Endocrinology 1988;123:1364–70.
   Google Scholar
• Liu JH, Lee DW, Markoff E. Differential release of prolactin variants in postpartum and early follicular phase women. J Clin Endocrinol Metab 1990;71:605–10.
   Google Scholar
• Baldocchi RA, Tan L, King DS, Nicoll CS. Mass spectro-metric analysis of the fragments produced by cleavage and reduction of rat prolactin: evidence that the cleaving enzyme is cathepsin D. Endocrinology 1993;133:935–8.
   Google Scholar
• Anthony PK, Powers CA. Characterization of cysteamine induction of the 22K prolactin variant in the rat pituitary. Neuroendocrinology 1993;57:167–76.
   Google Scholar
• Clapp C, Martial JA, Guzman RC, Rentier-Delure F, Weiner RI. The 16-kilodalton N-terminal fragment of human
   Google Scholar
• Kim J, Luo W, Chen DT, Earley K, Tunstead J, Yu-Lee LY, et al. Antitumor activity of the 16-kDa prolactin fragment in
   Google Scholar
• Tuazon PT, Lorenson MY, Walker AM, Traugh JA. p21-activated protein kinase gamma-PAK in pituitary secretory granules phosphorylates prolactin. FEBS Lett 2002;515:84–8.
   PubMed Web of Science ®Google Scholar
• Gout PW, Beer CT, Noble RL. Prolactin-stimulated growth of cell cultures established from malignant Nb rat lympho-mas. Cancer Res 1980;40:2433–6.
   Google Scholar
• Tanaka T, Shiu RP, Gout PW, Beer CT, Noble RL, Friesen HG. A new sensitive and specific bioassay for lactogenic hormones: measurement of prolactin and growth hormone in human serum. J Clin Endocrinol Metab 1980;51:1058–63.
   PubMed Web of Science ®Google Scholar
• Wicks JR, Brooks CL. Biological activity of phosphorylated and dephosphorylated bovine prolactin. Mol Cell Endocrinol 1995;112:223–9.
   Google Scholar
• Wang YF, Walker AM. Dephosphorylation of standard prolactin produces a more biologically active molecule: evidence for antagonism between nonphosphorylated and phosphorylated prolactin in the stimulation of Nb2 cell proliferation. Endocrinology 1993;133:2156–60.
   PubMed Web of Science ®Google Scholar
• Chen TJ, Kuo CB, Tsai KF, Liu JW, Chen DY, Walker AM. Development of recombinant human prolactin receptor antagonists by molecular mimicry of the phosphorylated hormone. Endocrinology 1998;139:609–16.
   PubMed Web of Science ®Google Scholar
• Kuo CB, Wu W, Xu X, Yang L, Chen C, Coss D, et al. Pseudophosphorylated prolactin (S179D PRL) inhibits growth and promotes beta-casein gene expression in the rat mammary gland. Cell Tissue Res 2002;309:429–37.
   PubMed Web of Science ®Google Scholar
• Schroeder MD, Brockman JL, Walker AM, Schuler LA. Inhibition of prolactin (PRL)-induced proliferative signals in breast cancer cells by a molecular mimic of phosphorylated PRL, S179D-PRL. Endocrinology 2003;144:5300–7.
   Google Scholar
• Wu W, Coss D, Lorenson MY, Kuo CB, Xu X, Walker AM. Different biological effects of unmodified prolactin and a molecular mimic of phosphorylated prolactin involve differ-ent signaling pathways. Biochemistry 2003;42:7561–70.
   PubMed Web of Science ®Google Scholar
• Bermchtein S, Kinet S, Jeay S, Llovera M, Madern D, Martial JA, et al. S179D-human PRL, a pseudophosphorylated human PRL analog, is an agonist and not an antagonist. Endocrinology 2001;142:3950–63.
   Google Scholar
• Bazan JF. A novel family of growth factor receptors: a common binding domain in the growth hormone, prolactin, erythropoietin and IL-6 receptors, and the p75 IL-2 receptor beta-chain. Biochem Biophys Res Commun 1989;164:788–95.
   PubMed Web of Science ®Google Scholar
• Bole-Feysot C, Goffin V, Edery M, Binari N, Kelly PA. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knock-out mice. Endocr Rev 1998;19:225–68.
   Google Scholar
• Clevenger CV, Furth PA, Hankinson SE, Schuler LA. The role of prolactin in mammary carcinoma. Endocr Rev 2003; 24:1–27.
   PubMed Web of Science ®Google Scholar
• Kline JB, Clevenger CV. Identification and characterization of the prolactin-binding protein in human serum and milk. J Biol Chem 2001;276:24760–6.
   PubMed Web of Science ®Google Scholar
• Shillingford JM, Miyoshi K, Robinson GW, Grimm SL, Rosen JM, Neubauer H, et al. Jak2 is an essential tyrosine kinase involved in pregnancy-mediated development of mammary secretory epithelium. Mol Endocrinol 2002; 16: 563–70.
   PubMed Web of Science ®Google Scholar
• Shillingford JM, Miyoshi K, Robinson GW, Bierie B, Cao Y, Karin M, et al. Proteotyping of mammary tissue from trans-markers: a tool to define developmental lesions. J Histochem Cytochem 2003;51:555–65.
   PubMedGoogle Scholar
• Liu X, Robinson GW, Wagner KU, Garrett L, Wynshaw-Boris A, Hennighausen L. Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev 1997;11: 179–86.
   Google Scholar
• Miyoshi K, Shillingford JM, Smith GH, Grimm SL, Wagner KU, Oka T, et al. Signal transducer and activator of transcription (Stat) 5 controls the proliferation and differ-entiation of mammary alveolar epithelium. J Cell Biol 2001; 155:531–42.
   PubMed Web of Science ®Google Scholar
• Erwin RA, Kirken RA, Malabarba MG, Farrar WL, Rui H. Prolactin activates Ras via signaling proteins SHC, growth factor receptor bound 2, and son of sevenless. Endocrinology 1995;136: 3512–8.
   Google Scholar
• Das R, Vonderhaar BK. Involvement of SHC, GRB2, SOS and RAS in prolactin signal transduction in mammary epithelial cells. Oncogene 1996;13:1139–45.
   PubMedGoogle Scholar
• Ali S. Recruitment of the protein-tyrosine phosphatase SHP-2 to the C-terminal tyrosine of the prolactin receptor and to the adaptor protein Gab2. J Biol Chem 2000;275:39073-80. Das R, Vonderhaar BK. Activation of raf-1, MEK, and MAP kinase in prolactin responsive mammary cells. Breast Cancer Res Treat 1996;40: 141–9.
   Google Scholar
• Das R, Vonderhaar BK. Activation of raf-1, MEK, and MAP kinase in prolactin responsive mammary cells. Breast Cancer Res Treat 1996;40:141–9.
   PubMed Web of Science ®Google Scholar
• Tessier C, Prigent-Tessier A, Ferguson-Gottschall S, Gu Y, Gibori G. PRL antiapoptotic effect in the rat decidua involves the PI3K/protein kinase B-mediated inhibition of caspase-3 activity. Endocrinology 2001;142:4086–94.
   PubMed Web of Science ®Google Scholar
• Fresno Vara JA, Caceres MA, Silva A, Martin-Perez J. Src family kinases are required for prolactin induction of cell proliferation. Mol Biol Cell 2001;12:2171–83.
   Google Scholar
• Pezet A, Favre H, Kelly PA, Edery M. Inhibition and restoration of prolactin signal transduction by suppressors of cytokine signaling. J Biol Chem 1999;274:24497-502. Lindeman GJ, Wittlin S, Lada H, Naylor MJ, Santamaria M, Zhang JG, et al. SOCS1 deficiency results in accelerated mammary gland development and rescues lactation in prolactin receptor-deficient mice. Genes Dev 2001;15:1631-6. Clevenger CV, Rycyzyn MA. Translocation and action of polypeptide hormones within the nucleus. Relevance to lactogenic transduction. Adv Exp Med Biol 2000;480:77-84. Rao YP, Olson MD, Buckley DJ, Buckley AR. Nuclear co-localization of prolactin and the prolactin receptor in rat Nb2 node lymphoma cells. Endocrinology 1993;133:3062-5. Rao YP, Buckley DJ, Olson MD, Buckley AR. Nuclear translocation of prolactin: collaboration of tyrosine kinase and protein kinase C activation in rat Nb2 node lymphoma cells. J Cell Physiol 1995;163: 266–76.
   Google Scholar
• Lindeman GJ, Wittlin S, Lada H, Naylor MJ, Santamaria M, Zhang JG, et al. SOCSl deficiency results in accelerated mammary gland development and rescues lactation in prolactin receptor-deficient mice. Genes Dev 2001;15:1631–6.
   PubMedGoogle Scholar
• Clevenger CV, Rycyzyn MA. Translocation and action of polypeptide hormones within the nucleus. Relevance to lactogenic transduction. Adv Exp Med Biol 2000;480:77–84.
   Google Scholar
• Rao YP, Olson MD, Buckley DJ, Buckley AR. Nuclear co-localization of prolactin and the prolactin receptor in rat Nb2 node lymphoma cells. Endocrinology 1993;133:3062–5.
   Google Scholar
• Rao YP, Buckley DJ, Olson MD, Buckley AR. Nuclear translocation of prolactin: collaboration of tyrosine kinase and protein kinase C activation in rat Nb2 node lymphoma cells. J Cell Physiol 1995;163:266–76.
   PubMed Web of Science ®Google Scholar
• Rycyzyn MA, Clevenger CV. Role of cyclophilins in somatolactogemc action. Ann N Y Acad Sci 2000;917:514–21.
   Google Scholar
• Rycyzyn MA, Clevenger CV. Role of cyclophilins in somatolactogenic action. Ann NY Acad Sci 2000917:514-21. Rycyzyn MA, Clevenger CV. The intranuclear prolactin/ cyclophilin B complex as a transcriptional inducer. Proc Natl Acad Sci USA 2002;99: 6790–5.
   Google Scholar
• Ormandy CJ, Camus A, Barra J, Damotte D, Lucas B, Buteau H, et al. Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes Dev 1997;11:167–78.
   PubMed Web of Science ®Google Scholar
• Horseman N, Zhao W, Montecino-Rodriquez E, Tanaka M, Nakashima K, Engle S, et al. Defective mammopoiesis, but normal hematipoiesis, in mice with targeted disruption of the prolactin gene. EMBO J 1997;16:101–110.
   Google Scholar
• Binart N, Helloco C, Ormandy CJ, Barra J, Clement-Lacroix P, Baran N, et al. Rescue of preimplantatory egg develop-ment and embryo implantation in prolactin receptor-defi-cient mice after progesterone administration. Endocrinology 2000;141:2691–7.
   Google Scholar
• Lucas BK, Ormandy CJ, Binart N, Bridges RS, Kelly PA. Null mutation of the prolactin receptor gene produces a defect in maternal behavior. Endocrinology 1998;139:4102–7.
   Google Scholar
• Bridges R, Rigero B, Byrnes E, Yang L, Walker A. Central infusions of the recombinant human prolactin receptor antagonist, S179D-PRL, delay the onset of maternal behavior in steroid-primed, nulliparous female rats. Endocrinology 2001;142: 730–9.
   Google Scholar
• Binart N, Melaine N, Pineau C, Kercret H, Touzalin AM, Imbert-Bollore P, et al. Male reproductive function is not affected in prolactin receptor-deficient mice. Endocrinology 2003;144:3779–82.
   Google Scholar
• Robertson FG, Harris J, Naylor MJ, Oakes SR, Kindblom J, Dillner K, et al. Prostate development and carcinogenesis in prolactin receptor knockout mice. Endocrinology 2003;144: 3196–205.
   PubMed Web of Science ®Google Scholar
• Steger RW, Chandrashekar V, Zhao W, Bartke A, Horseman ND. Neuroendocrine and reproductive functions in male mice with targeted disruption of the prolactin gene. Endo-crinology 1998;139:3691–5.
   Google Scholar
• Ormandy CJ, Binart N, Kelly PA. Mammary gland devel-opment in prolactin receptor knockout mice. J Mammary Gland Biol Neoplasia 1997;2:355–64.
   PubMed Web of Science ®Google Scholar
• Brisken C, Kaur S, Chavarria TE, Binart N, Sutherland RL, Weinberg RA, et al. Prolactin controls mammary gland development via direct and indirect mechanisms. Dev Biol 1999;210:96–106.
   PubMed Web of Science ®Google Scholar
• Brisken C, Park S, Vass T, Lydon JP, O'Malley BW, Weinberg RA. A paracrine role for the epithelial progester-one receptor in mammary gland development. Proc Natl Acad Sci USA 1998;95:5076–81.
   PubMed Web of Science ®Google Scholar
• Ormandy CJ, Naylor M, Harris J, Robertson F, Horseman ND, Lindeman GJ, et al. Investigation of the transcriptional changes underlying functional defects in the mammary glands of prolactin receptor knockout mice. Recent Prog Horm Res 2003;58:297–323.
   PubMedGoogle Scholar
• Vomachka A J, Pratt SL, Lockefeer JA, Horseman ND. Prolactin gene-disruption arrests mammary gland develop-ment and retards T-antigen-induced tumor growth. Onco-gene 2000;19:1077–84.
   Google Scholar
• Deome KB, Faulkin LJ, Jr, Bern HA, Blair PB. Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice. Cancer Res 1959;19: 515–20.
   Google Scholar
• Mueller S, Clark J, Myers P, Korach K. Mammary gland development in adult mice requires epithelial and stromal estrogen receptors. Endocrinology 2002;143:2357–2365.
   PubMed Web of Science ®Google Scholar
• Silberstein GB. Tumour-stromal interactions. Role of the stroma in mammary development. Breast Cancer Res 20013: 218–23.
   Google Scholar
• Wiesen JF, Young P, Werb Z, Cunha GR. Signaling through the stromal epidermal growth factor receptor is necessary for mammary ductal development. Development 1999;126:335–44.
   PubMed Web of Science ®Google Scholar
• Humphreys RC, Lydon J, O'Malley BW, Rosen JM. Mammary gland development is mediated by both stromal and epithelial progesterone receptors. Mol Endocrinol 1997; 11:801–11.
   Google Scholar
• Wiseman BS, Werb Z. Stromal effects on mammary gland development and breast cancer. Science 2002;296:1046–9.
   PubMed Web of Science ®Google Scholar
• Hovey RC, Trott JF, Ginsburg E, Goldhar A, Sasaki MM, Fountain SJ, et al. Transcriptional and spatiotemporal regulation of prolactin receptor mRNA and cooperativity with progesterone receptor function during ductal branch growth in the mammary gland. Dev Dyn 2001;222:192–205.
   Google Scholar
• Camarillo IG, Thordarson G, Moffat JG, Van Horn KM, Binart N, Kelly PA, et al. Prolactin receptor expression in the epithelia and stroma of the rat mammary gland. J Endocrinol 2001;171:85–95.
   Google Scholar
• Grimm SL, Seagroves TN, Kabotyanski EB, Hovey RC, Vonderhaar BK, Lydon JP, et al. Disruption of steroid and prolactin receptor patterning in the mammary gland corre-lates with a block in lobuloalveolar development. Mol Endocrinol 2002;16:2675–91.
   Google Scholar
• Naylor MJ, Lockefeer JA, Horseman ND, Ormandy CJ. Prolactin regulates mammary epithelial cell proliferation via autocrine/paracrine mechanism. Endocrine 2003;20:111–4.
   PubMedGoogle Scholar
• Saunier E, Dif F, Kelly PA, Edery M. Targeted expression of the dominant-negative prolactin receptor in the mammary gland of transgenic mice results in impaired lactation. Endocrinology 2003;144:2669–75.
   Google Scholar
• Binart N, Imbert-Bollore P, Baran N, Viglietta C, Kelly PA. A short form of the prolactin (PAL) receptor is able to rescue mammopoiesis in heterozygous PRL receptor mice. Mol Endocrinol 2003;17:1066–74.
   Google Scholar
• Brisken C, Socolovsky M, Lodish HF, Weinberg R. The signaling domain of the erythropoietin receptor rescues prolactin receptor-mutant mammary epithelium. Proc Natl Acad Sci USA 2002;99:14241–5.
   PubMed Web of Science ®Google Scholar
• Welsch CW, Nagasawa H. Prolactin and murine mammary tumorigenesis: a review. Cancer Res 1977;37:951–63.
   PubMed Web of Science ®Google Scholar
• Wennbo H, Gebre-Medhin M, Gritli-Linde A, Ohlsson C, Isaksson OG, Tornell J. Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice. J Clin Invest 1997;100:2744–51.
   PubMed Web of Science ®Google Scholar
• Rose-Hellekant TA, Arendt LM, Schroeder MD, Gilchrist K, Sandgren EP, Schuler LA. Prolactin induces ERalpha-positive and ERalpha-negative mammary cancer in transgenic mice. Oncogene 2003;22:4664–74.
   Google Scholar
• Ho KY, Weissberger A J. Characterization of 24-hour growth hormone secretion in acromegaly: implications for diagnosis and therapy. Clin Endocrinol (Oxf) 1994;41:75–83.
   PubMed Web of Science ®Google Scholar
• Yoshidome K, Shibata MA, Couldrey C, Korach KS, Green JE. Estrogen promotes mammary tumor development in C3(1)/5V40 large T-antigen transgenic mice: paradoxical loss of estrogen receptoralpha expression during tumor progression. Cancer Res 2000;60: 6901–10.
   Google Scholar
• Vonderhaar BK. Prolactin: the forgotten hormone of human breast cancer. Pharmacol Ther 1998;79:169–78.
   PubMedGoogle Scholar
• Ben-Jonathan N, Liby K, McFarland M, Zinger M. Prolactin as an autocrine/paracrine growth factor in human cancer. Trends Endocrinol Metab 2002;13:245–50.
   PubMed Web of Science ®Google Scholar
• Vonderhaar BK. Prolactin involvement in breast cancer. Endocr Relat Cancer 1999;6:389–404.
   Google Scholar
• Hankinson SE, Willett WC, Michaud DS, Manson JE, Colditz GA, Longcope C, et al. Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst 1999;91:629–34.
   PubMed Web of Science ®Google Scholar
• Bhatavdekar JM, Patel DD, Shah NG, Vora HH, Suthar TP, Ghosh N, et al. Prolactin as a local growth promoter in patients with breast cancer: GCRI experience. Eur J Surg Oncol 2000;26:540–7.
   Google Scholar
• Gill S, Peston D, Vonderhaar BK, Shousha S. Expression of prolactin receptors in normal, benign, and malignant breast tissue: an immunohistological study. J Clin Pathol 2001;54: 956–60.
   PubMed Web of Science ®Google Scholar
• McPherson K, Steel CM, Dixon JM. ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics. BM J 2000;321:624–8.
   Google Scholar
• Wang DY, de Stavola BL, Bulbrook RD, Allen DS, Kwa HG, Verstraeten AA, et al. The permanent effect of reproductive events on blood prolactin levels and its relation to breast cancer risk: a population study of postmenopausal women. Eur J Cancer Clin Oncol 1988;24:1225–31.
   PubMedGoogle Scholar
• Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breastcancer and 100 239 women without breast cancer from 54
   Google Scholar
• Mishell DR, Jr, Kletzky OA, Brenner PF, Roy S, Nicoloff J. The effect of contraceptive steroids on hypothalamic-pituitary function. Am J Obstet Gynecol 1977;128:60–74.
   PubMed Web of Science ®Google Scholar
• Lagiou A, Lagiou P, Vassilarou DS, Stoikidou M, Tricho-poulos D. Comparison of age at first full-term pregnancy between women with breast cancer and women with benign breast diseases. Int J Cancer 2003;107:817–21.
   Google Scholar
• Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet 2002;360:187–95.
   PubMed Web of Science ®Google Scholar
• Nevalainen MT, Valve EM, Ahonen T, Yagi A, Paranko J, Harkonen PL. Androgen-dependent expression of prolactin in rat prostate epithelium in vivo and in organ culture. FASEB J 1997;11:1297–307.
   Google Scholar
• Nevalainen MT, Valve EM, Ingleton PM, Nurmi M, Martikainen PM, Harkonen PL. Prolactin and prolactin receptors are expressed and functioning in human prostate. J Clin Invest 1997;99:618–27.
   Google Scholar
• Ahonen TJ, Harkonen PL, Laine J, Rui H, Martikainen PM, Nevalainen MT. Prolactin is a survival factor for androgen-deprived rat dorsal and lateral prostate epithelium in organ culture. Endocrinology 1999;140:5412–21.
   PubMed Web of Science ®Google Scholar
• Wennbo H, Kindblom J, Isaksson OG, Tornell J. Transgenic mice overexpressing the prolactin gene develop dramatic enlargement of the prostate gland. Endocrinology 1997;138: 4410–5.
   PubMed Web of Science ®Google Scholar
• Kindblom J, Dillner K, Sahlin L, Robertson F, Ormandy C, Tornell J, et al. Prostate hyperplasia in a transgenic mouse with prostate-specific expression of prolactin. Endocrinology 2003;144:2269–78.
   PubMed Web of Science ®Google Scholar
• Xu X, Wu W, Williams V, Khong A, Chen YH, Deng C, et al. Opposite effects of unmodified prolactin and a molecular mimic of phosphorylated prolactin on morphology and the expression of prostate specific genes in the normal rat prostate. Prostate 2003;54:25–33.
   Google Scholar
• Xu X, Wu W, Williams V, Khong A, Chen YH, Deng C, et al. Opposite effects of unmodified prolactin and a molecular mimic of phosphorylated prolactin on morphology and the expression of prostate specific genes in the normal rat prostate. Prostate 2003;54:25–33.
   Google Scholar
• Syms AJ, Harper ME, Griffiths K. The effect of prolactin on human BPH epithelial cell proliferation. Prostate 1985;6:145–53.
   Google Scholar
• Janssen T, Darro F, Petein M, Raviv G, Paste�is JL, Kiss R, et al. In vitro characterization of prolactin-induced effects on proliferation in the neoplastic LNCaP, DU145, and PC3 models of the human prostate. Cancer 1996;77: 144–9.
   Google Scholar
• Xu X, Kreye E, Kuo CB, Walker AM. A molecular mimic of phosphorylated prolactin markedly reduced tumor incidence and size when DU145 human prostate cancer cells were grown in nude mice. Cancer Res 2001;61:6098–104.
   PubMed Web of Science ®Google Scholar
• Bouchard B, Ormandy CJ, Di Santo JP, Kelly PA. Immune system development and function in prolactin receptor-deficient mice. J Immunol 1999;163:576–82.
   PubMed Web of Science ®Google Scholar
• Knshnan N, Thellin O, Buckley DJ, Horseman ND, Buckley AR. Prolactin suppresses glucocorticoid-induced thymocyte apoptosis in vivo. Endocrinology 2003;144:2102–10.
   Google Scholar
• Clement-Lacroix P, Ormandy C, Lepescheux L, Ammann P, Damotte D, Goffin V, et al. Osteoblasts are a new target for prolactin: analysis of bone formation in prolactin receptor knockout mice. Endocrinology 1999;140:96–105.
   Google Scholar
• Craven AJ, Ormandy CJ, Robertson FG, Wilkins RJ, Kelly PA, Nixon AJ, et al. Prolactin signaling influences the timing mechanism of the hair follicle: analysis of hair growth cycles in prolactin receptor knockout mice. Endocrinology 2001; 142:2533–9.
   Google Scholar
• Freemark M, Fleenor D, Driscoll P, Binart N, Kelly P. Body weight and fat deposition in prolactin receptor-deficient mice. Endocrinology 2001;142:532–7.
   Google Scholar
• McClellan KA, Robertson FG, Kindblom J, Wennbo H, Tornell J, Bouchard B, et al. Investigation of the role of prolactin in the development and function of the lacrimal and harderian glands using genetically modified mice. Invest Ophthalmol Vis Sci 2001;42:23–30.
   PubMed Web of Science ®Google Scholar
• Freemark M, Avril I, Fleenor D, Driscoll P, Petro A, Opara E, et al. Targeted deletion of the PRL receptor: effects on islet development, insulin production, and glucose tolerance. Endocrinology 2002;143:1378–85.
   PubMedGoogle Scholar
• Wakao H, Gouilleux F, Groner B. Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response. EMBO J 1994;13:2182–91.
   Google Scholar
• Gouilleux F, Wakao H, Mundt M, Groner B. Prolactin induces phosphorylation of Tyr694 of Stat5 (MGF), a prerequisite for DNA binding and induction of transcription. EMBO J 1994;13:4361–9.
   PubMed Web of Science ®Google Scholar
• Burdon TG, Maitland KA, Clark AJ, Wallace R, Watson CJ. Regulation of the sheep beta-lactoglobulin gene by lactogenic hormones is mediated by a transcription factor that binds an interferon-gamma activation site-related element. Mol En-docrinol 1994;8:1528–36.
   Google Scholar
• Li S, Rosen JM. Nuclear factor I and mammary gland factor (STAT5) play a critical role in regulating rat whey acidic protein gene expression in transgenic mice. Mol Cell Biol 1995;15:2063–70.
   PubMedGoogle Scholar
• Broadhurst MK, Wheeler TT. The p100 coactivator is present in the nuclei of mammary epithelial cells and its abundance is increased in response to prolactin in culture and in mammary tissue during lactation. J Endocrinol 2001;171: 329–37.
   Google Scholar
• Yahata T, Takedatsu H, Dunwoodie SL, Braganca J, Swingler T, Withington SL, et al. Cloning of mouse Cited4, a member of the CITED family p300/CBP-binding transcrip-tional coactivators: induced expression in mammary epithe-lial cells. Genomics 2002;80:601–13.
   PubMedGoogle Scholar
• Favy DA, Rio P, Maurizis JC, Hizel C, Bignon YJ, Bernard-Gallon DJ. Prolactin-dependent up-regulation of BRCA1 expression in human breast cancer cell lines. Biochem Biophys Res Commun 1999;258: 284–91.
   Google Scholar
• Brockman JL, Schroeder MD, Schuler LA. PRL activates the cyclin D1 promoter via the Jak2/Stat pathway. Mol Endocrinol 2002;16: 774–84.
   Google Scholar
• Brisken C, Ayyannan A, Nguyen C, Heineman A, Reinhardt F, Tan J, et al. IGF-2 is a mediator of prolactin-induced morphogenesis in the breast. Dev Cell 2002;3:877-87. Hovey RC, Harris J, Hadsell DL, Lee AV, Ormandy CJ, Vonderhaar BK. Local insulin-like growth factor-II mediates prolactin-induced mammary gland development. Mol En-docrinol 2003;17: 460–71.
   Google Scholar
• Fata JE, Kong YY, Li J, Sasaki T, Irie-Sasaki J, Moorehead RA, et al. The osteoclast differentiation factor osteoprote-gerin-ligand is essential for mammary gland development. Cell 2000;103:41–50.
   Google Scholar
• Srivastava S, Matsuda M, Hou Z, Bailey JP, Kitazawa R, Herbst MP, et al. Receptor activator of NF-kB ligand (RANKL) induction via Jak2 and Stat5a in mammary epithelial cells. J Biol Chem 2003;2:2.
   Google Scholar
• Brisken C, Heineman A, Chavarria T, Elenbaas B, Tan J, Dey SK, et al. Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling. Genes Dev 2000;14:650–4.
   PubMed Web of Science ®Google Scholar
• Kenney NJ, Smith GH, Rosenberg K, Cutler ML, Dickson RB. Induction of ductal morphogenesis and lobular hyper-plasia by amphiregulin in the mouse mammary gland. Cell Growth Differ 1996;7:1769–81.
   Google Scholar
• Luetteke NC, Qiu TH, Fenton SE, Troyer KL, Riedel RF, Chang A, et al. Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. Develop-ment 1999;126:2739–50.
   PubMed Web of Science ®Google Scholar
• Gass S, Harris J, Ormandy CJ, Brisken C. Using gene expression arrays to elucidate transcriptional profiles under-lying prolactin function. J Mammary Gland Biol Neoplasia 2003;8:269–285.
   PubMedGoogle Scholar
• Ganguly TC, O'Brien ML, Karpen SJ, Hyde JF, Suchy FJ, Vore M. Regulation of the rat liver sodium-dependent bile acid cotransporter gene by prolactin. Mediation of transcrip-tional activation by Stat5. J Clin Invest 1997;99:2906–14.
   PubMed Web of Science ®Google Scholar
• Yu-Lee LY, Hrachovy JA, Stevens AM, Schwarz LA. Interferon-regulatory factor 1 is an immediate-early gene under transcriptional regulation by prolactin in Nb2 T cells. Mol Cell Biol 1990;10: 3087–94.
   Google Scholar
• Frasor J, Gibori G. Prolactin regulation of estrogen receptor expression. Trends Endocrinol Metab 2003;14:118–23.
   PubMed Web of Science ®Google Scholar
• Feltus FA, Groner B, Melner MH. Stat5-mediated regulation of the human type II 3beta-hydroxysteroid dehydrogenase/ delta5-delta4 isomerase gene: activation by prolactin. Mol Endocrinol 1999;13: 1084–93.
   Google Scholar
• Albarracin CT, Parmer TG, Duan WR, Nelson SE, Gibori G. Identification of a major prolactin-regulated protein as 20 alpha-hydroxysteroid dehydrogenase: coordinate regulation of its activity, protein content, and messenger ribonucleic acid expression. Endocrinology 1994;134: 2453–60.
   Google Scholar
• Nanbu-Wakao R, Fujitani Y, Masuho Y, Muramatu M, Wakao H. Prolactin enhances CCAAT enhancer-binding protein-beta (C/EBP beta) and peroxisome proliferator-activated receptor gamma (PPAR gamma) messenger RNA expression and stimulates adipogenic conversion of NIH-3T3 cells. Mol Endocrinol 2000;14: 307–16.
   Google Scholar